genomiQa Pty Ltd logo — Whole-genome analysis and clinical reporting. CapeDx for can...

genomiQa Pty Ltd

Whole-genome analysis and clinical reporting. CapeDx for cancer patients, GulfDx for inherited diseases.

Founded 2017 Australia Australia 4 employees Biotechnology

General Information

Company Name genomiQa Pty Ltd
Founded Year 2017
Location Australia Australia +1
Employees 4
Industries Biotechnology
Social

Get notified when genomiQa Pty Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About genomiQa Pty Ltd

genomiQa Pty Ltd is an Australian biotechnology startup that specializes in whole-genome analysis and clinical reporting. The company's slogan, "Whole-genome analysis and clinical reporting. CapeDx for cancer patients, GulfDx for inherited diseases," highlights its focus on providing precision whole-genome analytics for routine clinical practice. genomiQa is currently developing two groundbreaking diagnostics, CapeDx and GulfDx. CapeDx aims to aid clinicians in selecting the best treatment for cancer patients and is touted as the most comprehensive cancer genomic test globally. While currently available for research, the company is expected to obtain NATA accreditation for Australia by mid-2020. On the other hand, GulfDx is designed to simplify the diagnostic process for inherited diseases through whole-genome analysis and clinical reporting. This diagnostic tool is also available for research, with NATA accreditation for Australia expected by the end of 2020. Established in 2017, genomiQa Pty Ltd has positioned itself as an innovative player in the biotechnology sector, aiming to bring cutting-edge genomic solutions into clinical practice. With its unique focus on whole-genome analytics and clinical reporting, the company stands at the forefront of revolutionizing the diagnostic process for both cancer and inherited diseases. While details of the last investment and investors are not specified, genomiQa's potential for setting new standards in genomic diagnostics makes it an intriguing prospect for venture capital investors seeking disruptive opportunities in the biotechnology space.

Taxonomy: genomics, clinical genomics, cancer research, genetic research, whole genome sequencing, precision medicine, oncology, biotech, pharmaceuticals, clinical trials, digital health, bioinformatics, RNAseq

No funding data available for genomiQa Pty Ltd yet.

Get notified when genomiQa Pty Ltd raises funding

genomiQa Pty Ltd Alternatives & Competitors

genomiQa Pty Ltd vs
Ashion Analytics
Ashion Analytics United States

We are an Exact Sciences sequencing-based Clinical laboratory. We tap into the power of the human ge...

3 employees
Biotechnology, Health Care
genomiQa Pty Ltd vs

Cancer Solved Together

338 employees
Health Care
genomiQa Pty Ltd vs
Cure Leukaemia
Cure Leukaemia United Kingdom

We fund the Trials Acceleration Programme (TAP) which delivers & connects patients to blood cancer c...

23 employees
Health Care

FAQ About genomiQa Pty Ltd

Whole-genome analysis and clinical reporting. CapeDx for cancer patients, GulfDx for inherited diseases.
genomiQa Pty Ltd was founded in 2017.
genomiQa Pty Ltd is headquartered in Australia.
genomiQa Pty Ltd operates in the following industries: Biotechnology.
genomiQa Pty Ltd has approximately 4 employees.
Top alternatives and competitors to genomiQa Pty Ltd include Ashion Analytics, Ontario Institute for Cancer Research, Cure Leukaemia, MNM Bioscience, Genomenon, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
genomiQa Pty Ltd and Ashion Analytics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors genomiQa Pty Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy